Ramesh Gadam
Radiation Oncology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ramesh Gadam’s office to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$1,266
Pharmacies billed $1,266 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 17% of their Part D prescriptions (16 of 92) in 2024. Above the middle of the specialty; the typical radiation oncology clinician is at 11%.
87 generic and fewer than 11 brand-name prescriptions · $1,266 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 14 | $254 | $18 |
| Gabapentin | 14 | $166 | $12 |
Year by year
| 2024 | 92 | 52 | 17% (16) | None | $1,266 |
| 2023 | 152 | 84 | 25% (38) | None | $6,076 |
| 2022 | 19 | 14 | None | None | $1,112 |
| 2020 | 21 | 11 | 0% (0) | None | $584 |
| 2019 | 83 | 40 | None | None | $2,039 |
| 2018 | 35 | 17 | None | None | $1,842 |
| 2017 | 19 | None | 0% (0) | None | $417 |
| 2016 | 196 | 28 | None | 9% | $7,323 |
| 2015 | 497 | 104 | 4% (19) | None | $24,951 |
| 2014 | 102 | 11 | None | None | $3,098 |
| 2013 | 58 | 12 | 0% (0) | 24% | $2,179 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Oxycodone | 25 | $688 | $28 |
| Triamcinolone Acetonide | 14 | $84 | $6 |
2019: 1 drug
| Cefdinir | 18 | $400 | $22 |
2016: 6 drugs
| Levothyroxine | 13 | $427 | $33 |
| Gabapentin | 15 | $376 | $25 |
| Atorvastatin | 12 | $239 | $20 |
| Omeprazole | 14 | $112 | $8 |
| Metoprolol | 16 | $49 | $3 |
| Amlodipine Besylate | 16 | $41 | $3 |
2015: 11 drugs
| Lantus | 16 | $5,059 | $316 |
| Levothyroxine | 27 | $565 | $21 |
| Metoprolol | 12 | $318 | $27 |
| Potassium Chloride | 11 | $289 | $26 |
| Atorvastatin | 17 | $284 | $17 |
| Amlodipine Besylate | 37 | $183 | $5 |
| Clindamycin | 14 | $135 | $10 |
| Lisinopril | 20 | $110 | $5 |
| Omeprazole | 13 | $102 | $8 |
| Ciprofloxacin | 12 | $63 | $5 |
| Simvastatin | 11 | $60 | $5 |
2014: 3 drugs
| Lisinopril | 15 | $61 | $4 |
| Hydrochlorothiazide | 13 | $26 | $2 |
| Furosemide | 12 | $24 | $2 |
Money from drug and device companies
$176 in 2025
| 2025 | 2 | 2 | None | $176 |
| 2024 | 1 | 2 | None | $50 |
| 2020 | 1 | 1 | None | $13 |
| 2019 | 2 | 2 | None | $27 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Elekta | None | $151 | 1 payment
|
| RefleXion Medical | Reflexion Medical Radiotherapy System | $25 | 1 payment
|
See all 2 published payments
| Elekta | Meals · 2025-09-27 | None | $151 |
| RefleXion Medical | Meals · 2025-04-22 | Reflexion Medical Radiotherapy System | $25 |
See earlier years (2024, 2020, 2019)
2024: $50
| RefleXion Medical | Reflexion Medical Radiotherapy System | $50 | 2 payments
|
2020: $13
| Novo Nordisk | Tresiba | $13 | 1 payment
|
2019: $27
| Pfizer | Bavencio | $15 | 1 payment
|
| Grifols USA | Prolastin-C Liquid | $13 | 1 payment
|
Professional record
- NPI
- 1679897284
- Licence
- KS 94-10845, NV 14813
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X); Internal medicine (207R00000X)
- Mailing address
- 902 N Riverside Rd Ste 201, Saint Joseph, MO, 64507
- NPI first listed
- 2010-03-25
- NPI last updated
- 2026-08-04
- NPI record certified
- 2026-08-04
This is when the NPI record was last certified, not a medical board exam.